| Not Yet Recruiting | Clonal Hematopoiesis of Immunological Significance NCT05969821 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation NCT03434730 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238 | University Health Network, Toronto | — |
| Recruiting | Italian Network MDS Registry NCT02808858 | Fondazione Italiana Sindromi Mielodisplastiche-ETS | — |
| Terminated | Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transpla NCT00813501 | City of Hope Medical Center | — |
| Terminated | Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With NCT00555048 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Tr NCT00787761 | Northside Hospital, Inc. | Phase 2 |
| Completed | Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia NCT00425477 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Ha NCT00410657 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacroli NCT00346359 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant NCT00281814 | The Cleveland Clinic | — |
| Completed | Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation NCT00281801 | Case Comprehensive Cancer Center | — |
| Completed | Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myel NCT00293410 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease NCT00719849 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder NCT00274820 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic NCT00611351 | University of Nebraska | Phase 2 |
| Terminated | Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer NCT00818961 | Northside Hospital, Inc. | Phase 2 |
| Completed | Campath-1H + FK506 and Methylprednisolone for GVHD NCT00109993 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced H NCT00096096 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes NCT00093366 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Terminated | G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders NCT00253552 | OHSU Knight Cancer Institute | N/A |
| Completed | Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes NCT00217386 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or Hig NCT00077558 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT C NCT00075816 | Medical College of Wisconsin | Phase 3 |
| Completed | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematol NCT00089037 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Mal NCT00068523 | Case Comprehensive Cancer Center | N/A |
| Completed | Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Tr NCT00066248 | University of South Florida | Phase 2 |
| Completed | Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic NCT00062140 | Fred Hutchinson Cancer Center | Phase 1 |
| Completed | Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hemat NCT00055653 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant fo NCT00265837 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 3 |
| Completed | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoi NCT00054340 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia NCT00052832 | University of Wisconsin, Madison | Phase 2 |
| Completed | Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS NCT00053287 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoi NCT00255710 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologi NCT00054236 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients NCT00082654 | Fred Hutchinson Cancer Center | N/A |
| Completed | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer NCT00036790 | University of Wisconsin, Madison | Phase 1 |
| Completed | NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders NCT00053989 | Roswell Park Cancer Institute | Phase 2 |
| Withdrawn | Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer NCT00301912 | University of California, San Francisco | Phase 2 |
| Completed | Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukem NCT00049634 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders NCT00544115 | City of Hope Medical Center | Phase 2 |
| Completed | MS-275 in Treating Patients With Hematologic Cancer NCT00015925 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer NCT00006239 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer NCT00054327 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA NCT00006379 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome NCT00004871 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00006042 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hemato NCT00044954 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer NCT00006225 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogen NCT00004896 | Northwestern University | Phase 2 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer NCT00290628 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leuke NCT00004899 | Northwestern University | Phase 2 |
| Completed | Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome NCT00003961 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transpl NCT00530218 | City of Hope Medical Center | Phase 2 |
| Completed | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic NCT00003913 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder NCT00004058 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Completed | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematolog NCT00003816 | Roswell Park Cancer Institute | Phase 2 / Phase 3 |
| Completed | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer NCT00003243 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions NCT00003336 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer NCT00003335 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00003116 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic NCT00002809 | Temple University | Phase 2 |
| Completed | Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With My NCT00002792 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia NCT00066417 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |